Product image of Neo-Sinefrina Alergo (Beclometasone Dipropionate) supplied by GNH India

Neo-Sinefrina Alergo

Active Ingredient:
Beclometasone Dipropionate
Origin:
EU

Neo-Sinefrina Alergo (Beclometasone Dipropionate)

Beclometasone dipropionate, the active ingredient in Neo‑Sinefrina Alergo, is a corticosteroid presented as a nasal spray for intranasal use. It is indicated for the treatment of allergic rhinitis, helping to reduce nasal inflammation, congestion and itching in adults and children.
GNH India supplies Neo‑Sinefrina Alergo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Omega Pharma Portuguesa Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Neo‑Sinefrina Alergo is a nasal corticosteroid used to manage inflammatory conditions of the nasal passages.

  • Allergic rhinitis: relieves nasal congestion, sneezing and itching caused by seasonal or perennial allergens.
  • Seasonal allergic rhinitis: reduces symptom severity during pollen seasons.
  • Perennial allergic rhinitis: provides ongoing control of year‑round nasal inflammation.

How It Works

  • Beclometasone dipropionate binds to intracellular glucocorticoid receptors in nasal mucosal cells, forming a receptor complex that translocates to the nucleus. This complex modulates gene transcription, decreasing production of pro‑inflammatory cytokines, chemokines and adhesion molecules, thereby reducing edema, mucus secretion and cellular infiltration in the nasal lining.

Side Effects

Adverse reactions may occur with intranasal use of beclometasone dipropionate.

Common Side Effects

  • Nasal irritation or burning sensation
  • Dryness of the nasal mucosa
  • Epistaxis (nosebleeds)
  • Headache
  • Altered taste or bitter taste
  • Throat irritation or cough

Serious or Rare Side Effects

  • Nasal septal perforation
  • Severe allergic reaction (anaphylaxis)
  • Vision changes such as cataracts or glaucoma
  • Adrenal suppression with prolonged high‑dose use
  • Opportunistic fungal infection of the nasal passages

Precautions & Warnings

Use Neo‑Sinefrina Alergo only as prescribed and limit duration to the shortest effective period.

  • Avoid prolonged continuous use: monitor for signs of local irritation or systemic effects.
  • Monitor patients with glaucoma or cataract risk: intra‑ocular pressure may increase.
  • Caution in diabetic patients: systemic absorption can affect glucose control.
  • Do not use if you have a known hypersensitivity to beclometasone or any excipients.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Beclometasone dipropionate may interact with other medications that affect corticosteroid metabolism or immune response.

Major Interactions (Avoid)

  • Systemic corticosteroids: increased risk of adrenal suppression.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local steroid exposure.
  • Antifungal agents that inhibit steroid metabolism.

Moderate Interactions (Monitor Closely)

  • Antihistamines: may enhance sedative effects when combined with first‑generation agents.
  • Decongestant nasal sprays: concurrent use may increase local irritation.
  • Immunosuppressants: monitor for heightened infection risk.

Frequently Asked Questions

Neo‑Sinefrina Alergo is an intranasal corticosteroid indicated for the relief of symptoms associated with allergic rhinitis, such as nasal congestion, sneezing, itching and runny nose.

Beclometasone dipropionate binds to glucocorticoid receptors in nasal mucosal cells, altering gene expression to suppress inflammatory cytokines, reduce edema and mucus production, and limit immune cell infiltration, thereby decreasing nasal inflammation.

The prescribed dose of Neo‑Sinefrana Alergo is determined by the treating clinician based on the patient’s age, severity of symptoms and response to therapy. Patients should follow the specific instructions provided by their healthcare professional.

Safety data for beclometasone dipropionate in pregnancy and lactation are limited. Use only if the potential benefit justifies the potential risk to the fetus or infant, and discuss any concerns with a qualified healthcare provider.

To request Neo‑Sinefrina Alergo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Neo‑Sinefrina Alergo contains beclometasone dipropionate, a potent glucocorticoid with a well‑established efficacy and safety profile. Compared with other nasal steroids such as fluticasone or mometasone, it offers similar anti‑inflammatory effects, but individual response and tolerability may vary, making clinician guidance essential.

Store Neo‑Sinefrina Alergo at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability.

Neo‑Sinefrina Alergo is administered as a nasal spray. The patient should gently blow the nose, insert the spray tip into one nostril, and actuate the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks, though rare, include nasal septal perforation, severe allergic reactions (anaphylaxis), adrenal suppression with prolonged high‑dose use, and opportunistic fungal infections of the nasal passages. Patients should report any unusual symptoms promptly to their healthcare provider.

Neo‑Sinefrina Alergo should be avoided in individuals with a known hypersensitivity to beclometasone dipropionate or any of its excipients, and in patients with active, untreated nasal infections or recent nasal surgery unless specifically advised by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Beclometasone Dipropionate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT